(UPG). UPG is a world-class, full-service manufacturer of precision plastic products and value-added services for the Medical, Industrial, and Datacenter markets, with operations in the U.S., China, Mexico, and Wales.
The addition of UPG's technological expertise, customer-first orientation and globally based facilities represent an ideal complement to MedPlast, according to Harold Faig, CEO of MedPlast.
"The combination of MedPlast and UPG represents tremendous opportunities for both firms and for our customers," Faig said. "MedPlast's enhanced global footprint and added technical capabilities will bring powerful synergies to customers looking for creative solutions to their design, development and manufacturing challenges."
The pairing of complementary technologies is a primary factor behind the acquisition, added Matt Langton, Vice President, Sales and Marketing of UPG. MedPlast's expertise includes injection molding, blow molding, silicone extrusion, compression and transfer molding, liquid injection molding (LIM), two-shot molding, over molding, insert molding, multi-component molding, and precision mold making. "UPG brings a wide range of value-added capabilities to the table, including partial- and full-assembly, contract sterilization, lab services as well as global supply chain and logistics management," said Langton.
"Having state of the art facilities in China, including precision mold making, will increase options for MedPlast customers," added Tom Opielowski, President of UPG China.
UPG also brings expertise in worldwide project management, while MedPlast offers customers complete solutions for processing elastomeric and silicone materials. Recently, MedPlast added silicone extrusion technology to its suite of services, providing its healthcare industry customers powerful capabilities that become even more valuable as the design of medical products grows increasingly more sophisticated and as cost pressures continue to mount.
The combination of MedPlast and UPG creates a global footprint with nine manufacturing locations in the U.S., four in China, one in Mexico, and one in Wales. This now includes precision mold making in both North America and China.
"The acquisition of UPG further enhances our position as an integrated, one-stop supplier for the healthcare and non-medical product markets," Faig said. "More than ever, we will offer our customers the efficiencies, support and expertise of a complete solutions provider.
"Our company's ability to provide a spectrum of innovative services, superior technical support, cost-control and the added convenience of our single-source supplier status represents tremendous value for our customers," Faig said.
The addition of UPG's technological expertise, customer-first orientation and globally based facilities represent an ideal complement to MedPlast, according to Harold Faig, CEO of MedPlast.
"The combination of MedPlast and UPG represents tremendous opportunities for both firms and for our customers," Faig said. "MedPlast's enhanced global footprint and added technical capabilities will bring powerful synergies to customers looking for creative solutions to their design, development and manufacturing challenges."
The pairing of complementary technologies is a primary factor behind the acquisition, added Matt Langton, Vice President, Sales and Marketing of UPG. MedPlast's expertise includes injection molding, blow molding, silicone extrusion, compression and transfer molding, liquid injection molding (LIM), two-shot molding, over molding, insert molding, multi-component molding, and precision mold making. "UPG brings a wide range of value-added capabilities to the table, including partial- and full-assembly, contract sterilization, lab services as well as global supply chain and logistics management," said Langton.
"Having state of the art facilities in China, including precision mold making, will increase options for MedPlast customers," added Tom Opielowski, President of UPG China.
UPG also brings expertise in worldwide project management, while MedPlast offers customers complete solutions for processing elastomeric and silicone materials. Recently, MedPlast added silicone extrusion technology to its suite of services, providing its healthcare industry customers powerful capabilities that become even more valuable as the design of medical products grows increasingly more sophisticated and as cost pressures continue to mount.
The combination of MedPlast and UPG creates a global footprint with nine manufacturing locations in the U.S., four in China, one in Mexico, and one in Wales. This now includes precision mold making in both North America and China.
"The acquisition of UPG further enhances our position as an integrated, one-stop supplier for the healthcare and non-medical product markets," Faig said. "More than ever, we will offer our customers the efficiencies, support and expertise of a complete solutions provider.
"Our company's ability to provide a spectrum of innovative services, superior technical support, cost-control and the added convenience of our single-source supplier status represents tremendous value for our customers," Faig said.
Companies in this article
